Skip to main content
ROIV
NASDAQ Life Sciences

罗旺特科学公司将股份回购计划提高至10亿美元

feedReported by Dow Jones Newswires
Sentiment info
Positive
Importance info
8
Price
$28.5
Mkt Cap
$19.932B
52W Low
$8.73
52W High
$29.2
Market data snapshot near publication time

summarizeSummary

罗旺特科学公司已将其股份回购授权增加5亿美元，使得该计划总额达到10亿美元。这一股份回购计划的扩张最初在公司2月6日的10-Q文件中提及，代表了一项重要的资本配置决策。10亿美元的授权表明管理层具有强烈的信心，并致力于将资本返还给股东，特别是在股票交易接近52周高位时。这种举动是在FDA接受brepocitinib的优先审查的最新消息之后，这表明公司正在战略性地使用资本来提高股东价值，并可能支持股价。交易者可能会将此视为积极的发展，表明公司具有财务实力，并主动地管理资本。

在该公告发布时，ROIV的交易价格为$28.50，交易所为NASDAQ，所属行业为Life Sciences，市值约为$199.3亿。 52周交易区间为$8.73至$29.20。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：Dow Jones Newswires。

show_chartPrice Chart

Share this article

Copied!

feed ROIV - Latest Insights

ROIV
Apr 20, 2026, 6:27 PM EDT
Filing Type: 4
Importance Score:
7
Roivant Sciences CEO Sells $8.45 Million in Shares Near 52-Week High
Sentiment: Negative
View Wiseek Article
ROIV
Apr 02, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Batoclimab Fails Phase 3 TED Studies; Roivant Expands Brepocitinib Program & Repurchases $109.7M Shares
Sentiment: Negative
View Wiseek Article
ROIV
Apr 02, 2026, 5:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Immunovant's Batoclimab Fails Phase 3 TED Trial; Roivant Expands Brepocitinib Program into New LPP Study
Sentiment: Negative
View Wiseek Article
ROIV
Mar 04, 2026, 3:04 PM EST
Source: Wiseek News
Importance Score:
9
$2.25B Moderna Settlement Boosts Roivant Sciences, Buyback Expanded to $1B
Sentiment: Positive
View Wiseek Article
ROIV
Mar 03, 2026, 5:11 PM EST
Source: Dow Jones Newswires
Importance Score:
8
Roivant Sciences Boosts Share Buyback Program to $1 Billion
Sentiment: Positive
View Wiseek Article
ROIV
Mar 03, 2026, 7:23 AM EST
Source: Wiseek News
Importance Score:
9
FDA Grants Priority Review to Brepocitinib NDA for Dermatomyositis, Decision Expected Q3 2026
Sentiment: Positive
View Wiseek Article
ROIV
Mar 03, 2026, 7:13 AM EST
Filing Type: 8-K
Importance Score:
9
FDA Grants Priority Review for Brepocitinib NDA in Dermatomyositis, Targeting Q3 2026 Launch
Sentiment: Positive
View Wiseek Article
ROIV
Feb 19, 2026, 4:24 PM EST
Filing Type: 144
Importance Score:
7
Officer Frank Torti Files Intent to Sell $38.5M in Shares Acquired via Option Exercise
Sentiment: Negative
View Wiseek Article
ROIV
Feb 13, 2026, 9:02 PM EST
Filing Type: 4
Importance Score:
8
Director Keith Manchester Sells $32.6 Million in Roivant Shares Amidst Broader Insider Distribution
Sentiment: Negative
View Wiseek Article
ROIV
Feb 13, 2026, 9:00 PM EST
Filing Type: 4
Importance Score:
8
Director Sells Over $32 Million in Roivant Sciences Shares Amidst Broader Insider Distribution
Sentiment: Negative
View Wiseek Article